Literature DB >> 19038891

Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.

Helen S Cox, Katia Sibilia, Silke Feuerriegel, Stobdan Kalon, Jonny Polonsky, Atadjan K Khamraev, Sabine Rüsch-Gerdes, Clair Mills, Stefan Niemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19038891     DOI： 10.1056/NEJMc0805644

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

1.  The scourge of tuberculosis and anti-tuberculosis drug resistance in Eastern Europe.

Authors:  Helen Cox; Nathan Ford
Journal:  Public Health Action       Date:  2014-10-21

2.  Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Authors:  Silke Feuerriegel; Helen S Cox; Nana Zarkua; Hamraev A Karimovich; Kai Braker; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

3.  Polymorphisms in isoniazid and prothionamide resistance genes of the Mycobacterium tuberculosis complex.

Authors:  Michaela Projahn; Claudio U Köser; Susanne Homolka; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2011-06-27       Impact factor: 5.191

Review 4.  Epidemiological models of Mycobacterium tuberculosis complex infections.

Authors:  Cagri Ozcaglar; Amina Shabbeer; Scott L Vandenberg; Bülent Yener; Kristin P Bennett
Journal:  Math Biosci       Date:  2012-03-01       Impact factor: 2.144

5.  PhyResSE: a Web Tool Delineating Mycobacterium tuberculosis Antibiotic Resistance and Lineage from Whole-Genome Sequencing Data.

Authors:  Silke Feuerriegel; Viola Schleusener; Patrick Beckert; Thomas A Kohl; Paolo Miotto; Daniela M Cirillo; Andrea M Cabibbe; Stefan Niemann; Kurt Fellenberg
Journal:  J Clin Microbiol       Date:  2015-04-08       Impact factor: 5.948

6.  Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa.

Authors:  Alistair D Calver; Alecia A Falmer; Megan Murray; Odelia J Strauss; Elizabeth M Streicher; Madelene Hanekom; Thelma Liversage; Mothusi Masibi; Paul D van Helden; Robin M Warren; Thomas C Victor
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

7.  Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs.

Authors:  Jongseok Lee; Derek T Armstrong; Willy Ssengooba; Jeong-Ae Park; Yeuni Yu; Francis Mumbowa; Carolyn Namaganda; Gerald Mboowa; Germine Nakayita; Sandra Armakovitch; Gina Chien; Sang-Nae Cho; Laura E Via; Clifton E Barry; Jerrold J Ellner; David Alland; Susan E Dorman; Moses L Joloba
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

8.  Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints.

Authors:  Stefan Niemann; Claudio U Köser; Sebastien Gagneux; Claudia Plinke; Susanne Homolka; Helen Bignell; Richard J Carter; R Keira Cheetham; Anthony Cox; Niall A Gormley; Paula Kokko-Gonzales; Lisa J Murray; Roberto Rigatti; Vincent P Smith; Felix P M Arends; Helen S Cox; Geoff Smith; John A C Archer
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

9.  Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa.

Authors:  Thomas R Ioerger; Sunwoo Koo; Eun-Gyu No; Xiaohua Chen; Michelle H Larsen; William R Jacobs; Manormoney Pillay; A Willem Sturm; James C Sacchettini
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

10.  Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies.

Authors:  Iñaki Comas; Susanne Homolka; Stefan Niemann; Sebastien Gagneux
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.